How This Evidence Evolved
Negative Pressure Wound Therapy
The rise of NPWT and the evidence for closed-incision applications
Timeline
Early observations and pilot data that first suggested a new direction
Landmark RCTs and pivotal trials that established the evidence base
Complete ulcer closure within 112 days: NPWT 43.2% versus advanced moist wound therapy 28.9% (P=0.007).
Disability Rating Index at 12 months
Postoperative surgical site infection, dehiscence, and time to complete healing: NPWT versus other dressings.
Follow-up studies, subgroup analyses, and real-world validation
Self-reported MHQ hand function at 7 days: negative-pressure versus static-pressure dressings (P=0.016).
NPWT instillation for chronic intrathoracic infection
Surgical-site infection after primary closure: NPWT 8.7% vs standard dressings 11.75% (RR 0.73, 95% CI 0.63–0.85); wound dehiscence RR 0.97 (95% CI 0.82–1.16)
Integration into clinical practice guidelines and recommendations
Current standard of care and ongoing research directions
Landmark Trials in This Story
Vacuum-assisted closure: a new method for wound control and treatment: clinical experience
Granulation tissue response in 300 treated wounds
Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: a multicenter randomized controlled trial.
Complete ulcer closure within 112 days: NPWT 43.2% versus advanced moist wound therapy 28.9% (P=0.007).
Negative-pressure wound therapy versus standard dressings for adults with an open lower limb fracture: the WOLLF RCT
Disability Rating Index at 12 months
Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention.
Postoperative surgical site infection, dehiscence, and time to complete healing: NPWT versus other dressings.
Donor site morbidity following radial forearm free flap reconstruction with split thickness skin grafts using negative pressure wound therapy.
Self-reported MHQ hand function at 7 days: negative-pressure versus static-pressure dressings (P=0.016).
Negative Pressure Wound Therapy Instillation for Management of Intrathoracic Chronic Infection
NPWT instillation for chronic intrathoracic infection
Negative pressure wound therapy for surgical wounds healing by primary closure.
Surgical-site infection after primary closure: NPWT 8.7% vs standard dressings 11.75% (RR 0.73, 95% CI 0.63–0.85); wound dehiscence RR 0.97 (95% CI 0.82–1.16)
Explore the evidence yourself
Ask AttendMe about any trial, guideline, or clinical question. Evidence-ranked answers from 3.7M+ peer-reviewed articles.